Latest news
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - StocktwitsStocktwits · Sat, 08 Aug 2026 06:08:41 GMTNovo Nordisk Stock Rises After GLP-1 Antitrust Win - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 19:52:31 GMTDebunked Episode 29: CMS GLP-1 Drug Pilot Program, RPM Strategy Raise Questions - MedCity NewsMedCity News · Thu, 06 Aug 2026 18:32:17 GMTLifeMD Reports Second Quarter 2026 Results, Reaches Branded GLP-1 Transition Milestone and Raises Full-Year Guidance - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 23:50:00 GMTCVS enhances supports for patients taking GLP-1s - Fierce HealthcareFierce Healthcare · Wed, 05 Aug 2026 17:56:35 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTEli Lilly Raises 2026 Sales Outlook After Strong GLP-1 Drug Demand - BinanceBinance · Wed, 05 Aug 2026 12:19:58 GMTNovo Nordisk Raises Full-Year Outlook Amid Strong GLP-1 Sales - Intellectia AIIntellectia AI · Tue, 04 Aug 2026 18:35:45 GMT